REG - Credit Suisse (Eur) - Post Stabilisation Notice-Givaudan Finance Eur BV.

Givaudan SAAnnouncement

15/05/2020 18:05

RNS Number : 1135N
  
Credit Suisse Securities (Eur) Ltd
  
15 May 2020
  
 

15th May 2020
 
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
 
Givaudan Finance Europe B.V.
 
Post-stabilisation Period Announcement
 
 
Further to the pre-stabilisation period announcement dated 15th April 2020, Credit Suisse Securities (Europe) Limited (contact: David Anthony; telephone: +44 (0) 20 7888 5805) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities. 
 



Issuer:


Givaudan Finance Europe B.V.




Guarantor (if any):


Givaudan SA




Aggregate nominal amount:


€500,000,000 & €500,000,000




Description:


Senior, Unsecured due 2027 & 2032




Stabilisation Manager(s):


Credit Suisse Securities (Europe) Limited




Offer price:


99.530 & 99.751



 
Although stabilisation offers were made, no stabilisation transactions were carried out.
 
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
 
This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.   
 
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
STAEAKSSFEFEEFA